Higher Risk of Mortality in HIV-HBV Co-Infected Patients from Sub-Saharan Africa Is Observed at Lower CD4 \textsuperscript+ Cell Counts
EHOLIÉ, Serge
Centre Hospitalier Universitaire de Treichville [Abidjan, Côte d'Ivoire] [CHU de Treichville]
Programme PAC-CI
Centre Hospitalier Universitaire de Treichville [Abidjan, Côte d'Ivoire] [CHU de Treichville]
Programme PAC-CI
LACOMBE, Karine
Institut Pierre Louis d'Epidémiologie et de Santé Publique [iPLESP]
CHU Saint-Antoine [AP-HP]
< Réduire
Institut Pierre Louis d'Epidémiologie et de Santé Publique [iPLESP]
CHU Saint-Antoine [AP-HP]
Langue
EN
Article de revue
Ce document a été publié dans
Antiviral Therapy. 2021-01-01, vol. 26, n° 1-2, p. 25--33
Résumé en anglais
Background Hepatitis B virus (HBV) co-infection in human immunodeficiency virus (HIV)-positive individuals increases the risk of overall mortality, especially when HBV DNA levels are high. The role of CD4 + cell counts in ...Lire la suite >
Background Hepatitis B virus (HBV) co-infection in human immunodeficiency virus (HIV)-positive individuals increases the risk of overall mortality, especially when HBV DNA levels are high. The role of CD4 + cell counts in this association is poorly defined. We aimed to determine whether HIV\textendash HBV co-infection influences changes in CD4 + cell count before and during antiretroviral therapy and whether it affects mortality risk at levels of CD4 + . Methods 2052 HIV-positive participants from Côte d'Ivoire in a randomized-control trial assessing early or deferred ART were included. HBV-status was determined by hepatitis B surface antigen (HBsAg). Changes in CD4 + cell levels were estimated using a mixed-effect linear model. The incidence rates of all-cause mortality were estimated at CD4 + counts ≤q350, 351\textendash 500, >500/mm 3 and were compared between HBV-status groups as incidence rate ratios (IRR). Results At baseline, 190 (9%) were HBsAg-positive [135 (71%) with HBV DNA 500/mm 3 (adjusted-IRR = 1.07, 95% CI = 0.01\textendash 4.91). Conclusion Despite no effect of HBV-infection on CD4 + levels, HIV-HBV co-infected individuals with high HBV replication are at higher risk of mortality when CD4 + is <500/mm 3 .< Réduire
Unités de recherche